Red Blood Cell Transfusion in Very Premature Infants and HAS 2014 Guideline

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

57 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-22

Study Completion Date

2018-01-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The indications that motivated the decision to transfuse (or not) were analyzed to verify compliance with HAS recommendations. Medical records from 57 premature infants \< 32 weeks hospitalized between 2016 -2017 were retrospectively analysed, especially all the events related to monitoring of hemoglobin level and RBC transfusions during the first month of life. The criteria (postnatal age, rate of haemoglobin, type of breathing assistance, oxygen needing, medullary regeneration) on which rely the decision process in the HAS algorithm for the RBC transfusion were also considered, as well as the final decision actually adopted for each case (transfused/ not transfused). All this made it possible to determine the kappa coefficient for evaluation of agreement with HAS new guidelines in the investigator's medical staff.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Liberal Versus Restrictive Transfusion Guidelines for Preterm Infants

NCT00369005

Infant, Premature Anemia Intracranial Hemorrhages +2 more

COMPLETED NA

Normal Hemostasis Values in Premature Infants

NCT07349251

Premature Infant, Hemostasis

RECRUITING

Combining Restrictive Guidelines and a NIRS SCORE to Decrease RBC Transfusions

NCT02535208

Anemia of Prematurity (AOP)

COMPLETED NA

Transfusions and Nitric Oxide Level in Preterm Infants

NCT00787124

Prematurity Anemia Necrotizing Enterocolitis

COMPLETED

Monitoring Outcome in Neonatal Thrombocytopenia

NCT03110887

Neonatal Thrombocytopenia Intraventricular Hemorrhage Platelet Transfusion

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Practice Guideline of Erythrocyte Transfusion in Preterm Infant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* preterm infant hospitalized in Amiens School hospital (CHU Amiens-Picardie) between October 2016 and April 2017 during the first month of life, with allowed access on data recorded in medical files concerning the evolution of clinical characteristics (body weight,…) and the results of laboratory analyses performed during this initial hospital stay.

Exclusion Criteria

* less than 25 weeks or more than 32 weeks at birth
* any hemoglobin dosage during the hospital stay
* serious congenital malformation
* known or documented neonatal red blood cell disease (inherited hemolysis, enzymopathy of red blood cell membrane,…)

Eligible Sex

ALL

Accepts Healthy Volunteers

No